Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Longview Acquisition Corp. II (LGV : NYSE)

• Company Description    Longview Acquisition Corp. II entered into a definitive business combination agreement with HeartFlow Holding Inc. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $10.09 Daily Weekly Monthly 20 Day Moving Average: 0 shares Shares Outstanding: 86.25 (millions) Market Capitalization: $870.26 (millions) Beta: 0.04 52 Week High: $10.15 52 Week Low: $9.75 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -3.79% 12 Week 0.00% -7.17% Year To Date 0.00% -9.04%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 767 FIFTH AVENUE 44TH FLOOR - NEW YORK,NY 10153 USA ph: 212-812-4700 fax: - info@longviewacquisition.com http://www.longviewacquisition.com

• General Corporate Information    Officers John Rodin - ChiefExecutiveOfficer Larry Robbins - Chairman Mark Horowitz - ChiefFinancialOfficer Westley Moore - Director Shalinee Sharma - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 54319Q105 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 86.25 Most Recent Split Date: (:1) Beta: 0.04 Market Capitalization: $870.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 117.59 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/23 - - 12/31/22 - - 09/30/22 - -65.52 ROA 03/31/23 - - 12/31/22 - - 09/30/22 - 3.65 Current Ratio 03/31/23 - - 12/31/22 - - 09/30/22 - 0.07 Quick Ratio 03/31/23 - - 12/31/22 - - 09/30/22 - 0.07 Operating Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Net Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Pre-Tax Margin 03/31/23 - - 12/31/22 - - 09/30/22 - - Book Value 03/31/23 - - 12/31/22 - - 09/30/22 - -0.38 Inventory Turnover 03/31/23 - - 12/31/22 - - 09/30/22 - - Debt-to-Equity 03/31/23 - - 12/31/22 - - 09/30/22 - - Debt-to-Capital 03/31/23 - - 12/31/22 - - 09/30/22 - -

Powered by Zacks Investment Research ©